ALK-Abelló A/S (OTC:AKBLF) Shares Up 5.2% – Should You Buy?

ALK-Abelló A/S (OTC:AKBLFGet Free Report)’s share price shot up 5.2% during mid-day trading on Tuesday . The stock traded as high as $21.35 and last traded at $21.35. 500 shares were traded during trading, an increase of 67% from the average session volume of 300 shares. The stock had previously closed at $20.30.

ALK-Abelló A/S Trading Up 5.2 %

The firm has a fifty day simple moving average of $21.27 and a 200-day simple moving average of $22.83.

ALK-Abelló A/S Company Profile

(Get Free Report)

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.

Read More

Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.